Nancy E. Kohl - Concepedia

Author

Nancy E. Kohl

United States Military Academy ORCID

Also Known As

Kohl, Nancy E., N E Kohl, N Kohl, N Köhl, N. Kohl, N. Köhl, N.E. Kohl, Nancy E Kohl, Nancy E. Kohl, Nancy Kohl

222

Publications

12.4K

Citations

H-Index

103

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Columbia University Dana-Farber Cancer Institute Blueprint Medicines (United States)

About

Nancy E. Kohl is an author at United States Military Academy specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	64	8.8K
2	Natural Sciences	29	34	3K
3	Biochemistry	28	32	2.8K
4	Health Sciences	3	3	63
5	Engineering	2	2	129

Nancy E. Kohl

Publications

12.1K

Citations

H-Index

Page 1

	Year	Citations
Active human immunodeficiency virus protease is required for viral infectivity. Nancy E. Kohl, Emilio A. Emini, William A. Schleif, Proceedings of the National Academy of Sciences Protease InhibitorsViral ReplicationMolecular VirologyHiv ProteaseHuman Retrovirus	1988	1.3K
Transposition and amplification of oncogene-related sequences in human neuroblastomas Nancy E. Kohl, Naotoshi Kanda, Rhona Schreck, Cell Neuro-oncologyOncogenic AgentHuman NeuroblastomasNeuroblastsMedicine	1983	728
Selective Inhibition of <i>ras</i> -Dependent Transformation by a Farnesyltransferase Inhibitor Nancy E. Kohl, Scott D. Mosser, S. J. DESOLMS, Science Molecular BiologyChemical BiologyRas ProcessingTumor BiologyMolecular Pharmacology	1993	579
Differential expression of myc family genes during murine development Kathryn A. Zimmerman, George D. Yancopoulos, Robert G. Collum, Nature Developmental BiologyGeneticsMyc Family GenesGene RegulationGene Characterization	1986	544
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice Nancy E. Kohl, Charles A. Omer, Michael W. Conner, Nature Medicine Farnesyltransferase Induces RegressionTumor BiologyChemoprevention StrategyOncogenic AgentMedicine	1995	538
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model David A. Reardon, Prafulla C. Gokhale, Sarah R. Klein, Cancer Immunology Research	2015	422
Mediator kinase inhibition further activates super-enhancer-associated genes in AML Henry E. Pelish, Brian B. Liau, I Niţulescu, Nature Mediator Kinase InhibitionTranscriptional RegulationSignal TransductionSignaling PathwayCell Regulation	2015	391
Lung Cancer Cell Lines Harboring <i>MET</i> Gene Amplification Are Dependent on Met for Growth and Survival Bart Lutterbach, Qinwen Zeng, Lenora J. Davis, Cancer Research	2007	316
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway Margit Hagel, Chandra Miduturu, Michael P. Sheets, Cancer Discovery	2015	305
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Nancy E. Kohl, Francine R. Wilson, S D Mosser, Proceedings of the National Academy of Sciences PathologyCancer BiologyTumor BiologyOncologyCancer Cell Biology	1994	286

Page 1